IL-22, GM-CSF and IL-17 in peripheral CD4(+) T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy

Multiple sclerosis (MS) is thought to be a Th17-mediated dysimmune disease of the central nervous system. However, recent publications have questioned the pathogenicity of IL-17 per se and rather suggest the implication of other Th17-related inflammatory mediators. Therefore, we studied the expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Muls, Nathalie, Nasr, Zakia, Dang, Hong Anh, Sindic, Christian, van Pesch, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354390/
https://www.ncbi.nlm.nih.gov/pubmed/28301515
http://dx.doi.org/10.1371/journal.pone.0173780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354390/
https://www.ncbi.nlm.nih.gov/pubmed/28301515
http://dx.doi.org/10.1371/journal.pone.0173780

Ejemplares similares